A Federal Register notice from FDA addressed comments on the guidance on Proprietary Naming of Biological Products and the agency’s decision to require applicants to submit up to ten proposed, ...
In a new draft guidance, FDA proposes the use of a nonproprietary name plus a four-letter suffix to identify all biologic products, both new and old. The long-awaited draft guidance on biosimilar ...
Can you guys think of any common modern prefixes and suffixes besides:<BR><BR><B>i</B>Pod<BR><B>e</B>Donkey<BR>Nap<B>ster</B><BR><B>Net</B>Trends<BR>Pow<B>web</B><BR ...
ARLINGTON, Va., May 13, 2019 /PRNewswire/ -- US physicians and patient advocacy organizations expressed their overwhelming support for the FDA's suffix-based naming system for biologic medicines and ...
THE first use of the prefix ‘nor’ appears to be in a paper by Matthiessen and Foster 1 published in 1868. They were studying the nitrogen-free substance opianic acid formed by the oxidation of ...
The agency reiterated its earlier decision to require suffixes in biosimilar naming, but was unclear on suffix meaning. A Federal Register notice from FDA addressed comments on the guidance on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results